One stock that might be an intriguing choice for investors right now is Accolade, Inc. (ACCD) . This is because this security in the Technology Services space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place in the Technolo ...

andreswd Overview My recommendation for Accolade (NASDAQ:ACCD) is a buy rating, as I remain convicted that ACCD can grow 20% in FY25, driven by a strong core demand, health care plan strategy, GLP-1, and elevated demand for expert medical opinion. Note that I previously rated buy rating for ACCD as I expected ACCD to continue executing as guided and growing the business as I expected. As ACCD executes, valuation should re-rate to historical levels. Indeed, I believe the market recognized that valuation was ...

Accolade, Inc. (NASDAQ:ACCD) Q3 2024 Earnings Call Transcript January 8, 2024 4:30 PM ET Company Participants Todd Friedman - SVP, IR Rajeev Singh - CEO Steve Barnes - CFO Conference Call Participants Ryan Daniels - Blair Craig Hettenbach - Morgan Stanley Ryan MacDonald - Needham Jailendra Singh - Truist Stan Berenshteyn - Wells Fargo Jessica Tassan - Piper Sandler Richard Close - Canaccord Genuity Allen Lutz - Bank of America Stephanie Davis - Barclays Jenny Shen - BTIG Jack Wallace - Guggenheim Partners O ...

January 2024 NASDAQ: ACCD ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________________________ FORM 10-Q ______________________________________________________ x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39348 ACCOLADE, INC. (Exa ...

SEATTLE, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD) today announced that it will be presenting at the following upcoming investor conferences: 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 11 at 7:30am PT26th Annual Needham Growth Conference in New York on Thursday, January 18 at 3:00pm ET A webcast of these events will be available at ir.accolade.com and a replay will be available for 90 days. About Accolade, Inc. Accolade (NASDAQ:ACCD) is a Persona ...

Accolade, Inc. (NASDAQ:ACCD) Q2 2024 Earnings Conference Call October 4, 2023 4:30 PM ET Company Participants Todd Friedman - Senior Vice President, Investor Relations Rajeev Singh - Chief Executive Officer Steve Barnes - Chief Financial Officer Shantanu Nundy - Executive Vice President, Care Delivery and Chief Health Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Jessica Tassan - Piper Sandler Jailendra Singh - Truist Securities Jared Haase - William Blair Glen Santangelo - Jefferie ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39348 ACCOLADE, INC. (Exact name of registrant as specified in its charter) Delaware 01-0969591 (State or Other Juri sdiction of (I.R.S. ...

Accolade, Inc. (NASDAQ:ACCD) Q1 2024 Earnings Conference Call June 29, 2023 4:30 PM ET Company Participants Todd Friedman - SVP, IR Rajeev Singh - CEO Steve Barnes - CFO Shantanu Nundy - Chief Health Officer Conference Call Participants Ryan Daniels - Blair Craig Hettenbach - Morgan Stanley Jeff Garrow - Stephens, Inc. Jessica Tassan - Piper Sandler Stephanie Davis - SVB Securities Ryan MacDonald - Needham and Company Jonathan Yong - Credit Suisse Jailendra Singh - Truist Securities Sandy Draper - Guggenhei ...

Accolade Inc. Investor Presentation This presentation contains “forward-looking statements” –that is, statements related to future, not past, events. In this context, forward-looking statements often address our expected future business and financial performance and financial condition, and often contain words such ‘‘anticipate,’’ ‘‘believe,’’ ‘‘contemplate,’’ ‘‘continue,’’ ‘‘could,’’ ‘‘estimate,’’ ‘‘expect,’’ “guidance,” ‘‘intend,’’ ‘‘may,’’ ‘‘plan,’’ ‘‘potential,’’ ‘‘predict,’’ ‘‘project,’’ ‘‘should,’’ ‘‘ ...